GLP-1R agonists’ type 2 diabetes and obesity market to reach $125 billion in 7MM by 2033: GlobalData Read more
GLP-1R agonists clinical trial design needs to be improved to reassure drugs’ benefits: GlobalData Read more
Glenmark Pharma launches triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin in India Read more
China poised to lead the way with world’s first oral insulin for type 2 diabetes: GlobalData Read more
Bayer gets US FDA nod for KERENDIA (finerenone) to treat CKD associated with type 2 diabetes Read more
Mankind Pharma seeks CDSCO approval for Phase 1 Clinical Trials of patented anti-diabetic molecule Read more